Huntsman Cancer Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Huntsman Cancer Institute
Nov 17, 2024, 12:20 | Blog
Sendurai Mani: Huntsman Cancer Institute - a truly inspiring place that fosters cutting-edge research and collaboration
Sendurai Mani, Dean Chair for Translational Oncology at Brown University Warren Alpert Medical School, shared…
Oct 14, 2024, 15:14 | Drugs
Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC
Toni Choueiri shared on X: ''JUST IN: HUGE NEWS ==> OS benefit from TALAPRO-2 study…
Oct 12, 2024, 22:08 | Insight
Sumanta Pal: The 1st study to show an OS benefit with ARPI + PARP in mCRPC
Sumanta Pal shared a post on X: “Woke up to this incredible news from the…
Oct 11, 2024, 17:45 | Blog
Andrea Apolo about the latest trials and practice changes in bladder cancer
Bogdana Schmidt, Urologic Oncologist at Huntsman Cancer Institute, shared a post about a conversation with…
Oct 11, 2024, 14:13 | Blog
Georges Gebrael awarded Susan Cooper Jones Fellowship in Cancer Research
University of Utah Department of Internal Medicine posted the following on X: “Congratulations to Georges…
Oct 7, 2024, 07:58 | Blog
October is Liver Cancer Awareness Month
Liver Cancer Awareness Month, observed every October, serves as a crucial platform to raise awareness…
Sep 20, 2024, 12:57 | Blog
Neeraj Agarwal: The 1st results of the ph3 Niagara trial of cisplatin + gemcitabine +/- durvalumab in MIBC
Neeraj Agarwal shared a post on X: "Breaking news (practice changing) from ESMO24, Tom Powles…
Sep 17, 2024, 18:42 | Blog
Neeraj Agarwal: The stats on the ESMO24 meeting at the presidential dinner
Neeraj Agarwal shared a post on X: "ESMO presidential dinner. ESMO President Andres Cervantes provided the…
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 13, 2024, 13:59 | Insight
Article of the day, September 13th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 1, 2024, 04:35 | Insight
Heloisa Soares: Thrilled to attend my first ASCO Government Relations Committee meeting!
Heloisa Soares, Medical Director of Clinical Trials Office at Huntsman Cancer Institute, shared on X:…
Aug 29, 2024, 16:36 | Blog
Highlights from IBCG24 Retreat
The International Bladder Cancer Group (IBCG) hosted a session at the American Urological Association (AUA)…
Aug 28, 2024, 13:52 | Insight
Article of the day, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 8, 2024, 09:07 | Blog
Some who experience early menopause may be at increased risk for Breast Cancer
Julie Kiefer, Director of Research Communications at the University of Utah Health, shared on X:…
Aug 5, 2024, 02:38 | Insight
Umang Swami: Evaluating TRT trends in nonmetastatic castration-resistant prostate cancer
Umang Swami, Oncologist at Huntsman Cancer Institute, University of Utah, shared a post on X about…
Aug 4, 2024, 17:24 | Blog
Neeraj Agarwal: Liquid epigenomic profiling to diagnose RCC patients with residual disease surgery
Neeraj Agarwal shared on X: "Another stellar talk by David Braun in World GU Conference…
Aug 4, 2024, 12:48 | Insight
Neeraj Agarwal: Recommendations on bladder preservation in MIBC at the WorldGU24
Neeraj Agarwal shared on X: “Recommendations on bladder preservation in MIBC bladder-cancer by the IBCG…
Jul 29, 2024, 07:38 | Blog
Manni Mohyuddin: My personal preference on T cell redirecting therapy for triple class refractory off trial
Manni Mohyuddin shared a post on X: "In absence of head to head data, my…
Jul 25, 2024, 00:44 | Opinion
Manni Mohyuddin: The results of the GEM-CESAR trial are a stunning verdict against early intervention in SMM
Manni Mohyuddin shared on X: "The GEM-CESAR trial of a super aggressive approach to SMM…
Jul 21, 2024, 21:50 | Blog
Women with endometriosis have a significant increased risk of developing ovarian cancer
Huntsman Cancer Institute posted on X about recent paper by Jennifer Doherty et al., commenting: "A…
Jul 21, 2024, 20:01 | Blog
Assessing bone pain and survival in SWOG Cancer Research Network 1216 TAK700 in hormone sensitive prostate cancer
Sumanta K.Pal shared a post on X about a recent paper by Georges Gebrael et al.,…
Jul 15, 2024, 11:30 | Blog
Neeraj Agarwal: Excellent talk by Michelle Hirsch on the pathology diagnosis of RCC variants
Neeraj Agarwal shared on X: "Surgical Pathology Toolbox and Technological Advances to Solve Kidney Cancer…
Jul 14, 2024, 06:27 | Blog
Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Jul 14, 2024, 03:00 | Insight
Comprehensive talk on treatment options in adjuvant RCC by Bradley McGregor
Neeraj Agarwal shared on X: "Emerging treatment options in adjuvant RCC kidney cancer setting, comprehensive…
Jul 12, 2024, 13:32 | Societies
Insights from KCRS24 by Neeraj Agarwal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in…
Jul 4, 2024, 14:21 | Insight
A critical appraisal of the long-term follow-up of CASSIOPEIA trial by Manni Mohyuddin
Manni Mohyuddin shared a post on X: "A critical appraisal of the long-term follow-up of…
Jul 4, 2024, 12:08 | Societies
Neeraj Agarwal and Rana McKay highlight key studies in urothelial and renal cell carcinomas
The American Society of Clinical Oncology (ASCO) shared on X: "Neeraj Agarwal of Huntsman Cancer…
Jul 3, 2024, 23:28 | Insight
Neeraj Agarwal: Amazing performance by the stellar Genitourinary Cancer Research Team's junior investigators
Neeraj Agarwal shared a post on X: "Amazing performance by the stellar Genitourinary Cancer Research…
Jul 1, 2024, 12:00 | Blog
Shilpa Gupta: Congrats Neeraj Agarwal on another stellar achievement
Shilpa Gupta shared on X/Twitter: "Congrats Neeraj Agarwal on yet another stellar achievement! And for…
Jun 24, 2024, 07:13 | Blog
Manni Mohyuddin: This is a testament to the fact that trainees appreciate critical appraisal
Manni Mohyuddin shared a post by Raj Chakraborty, Assistant Professor of Medicine at Columbia University…
Jun 24, 2024, 01:48 | Insight
Novel PARP inhibitor saruparib in metastatic hormone-sensitive prostate cancer
UroToday shared a post on X:           . "The EvoPAR-Prostate 01 Trial:…
Jun 24, 2024, 00:16 | Blog
Huntsman Cancer Institute Collaborative Award for RO1 grant  
Umang Swami, Assistant Professor at Huntsman Cancer Institute, University of Utah, shared a post on X:…
Jun 19, 2024, 01:26 | Blog
Ami Patel: An honor to work with Naveen Pemmaraju on MPN review article
Ami Patel, Hematologist at Huntsman Cancer Institute, shared a post by Naveen Pemmaraju on X, adding: “An…
May 29, 2024, 04:29 | Blog
We were honored to welcome Dr. Monica Bertagnolli for a tour of our state-of-the-art facilities - Huntsman Cancer Institute
Huntsman Cancer Institute shared on LinkedIn: "Last week, we were honored to welcome Dr. Monica Bertagnolli,…
May 29, 2024, 02:38 | Blog
Manni Mohyuddin: On June 8th, I ride at the Huntsman Cancer Institute sportsfest
Manni Mohyuddin shared on X: "On June 8th, I ride at the Huntsman Cancer Institute…
May 27, 2024, 09:12 | Blog
Umang Swami: Honored to be part of ASCO Guideline Panel
Umang Swami, Assistant Professor in the Department of Oncology at Huntsman Cancer Institute, shared on…
May 26, 2024, 06:02 | Insight
Toni Choueiri: The work of Eddy Saad, Eli Van Allen, Sasha Gusev being highlighted here at ASCO24
Toni Choueiri shared a post by Neeraj Agarwal on X/Twitter: "The work of Eddy Saad, Eli Van…
May 25, 2024, 09:57 | Societies
Manni Mohyuddin: Six key take-aways regarding the IMROZ trial while we wait for ASCO 24
Manni Mohyuddin shared on X: "The IMROZ trial (Isa-VRd versus VRd for transplant-ineligible myeloma) just…
May 24, 2024, 01:29 | Blog
Kicking off the Female Leaders in Cancer panel with a message from Kimryn Rathmell - NACCDO-PAMN
Kimryn Rathmell shared a post by NACCDO-PAMN on X/Twitter: "Thank you, NACCDO-PAMN communicators and development officers, for your…
May 16, 2024, 09:08 | Blog
Bogdana Schmidt: I am lucky to have an amazing team!
Bogdana Schmidt, urologic surgeon specializing in urologic oncology at the University of Utah, shared a post…
May 15, 2024, 08:55 | Insight
Manni Mohyuddin: Philanthropy has allowed us to conduct trials looking at less is more approaches
Manni Mohyuddin shared on X: “I'm participating in the Huntsman SportsFest ride this June. Philanthropy…
May 13, 2024, 07:53 | Blog
David W. Wetter honored with the Society of Behavioral Medicine Senior Investigator Award - Huntsman Cancer Institute
Neli Ulrich, Chief Scientific Officer and Executive Director of the Comprehensive Cancer Center at Huntsman…
May 9, 2024, 00:05 | Blog
Fumiko Ladd Chino: Why I think SoMe is essential for the next gen of academic physicians
Fumiko Ladd Chino shared a post by Gita Suneja, Radiation Oncologist at Huntsman Cancer Institute, on…
May 8, 2024, 07:21 | Insight
Umang Swami: Prior NHT in patients with MCRPC
Umang Swami, Assistant Professor in the Department of Oncology at Huntsman Cancer Institute, shared on…
May 6, 2024, 08:34 | Insight
Manni Mohyuddin: Ten important observations about myeloma
Manni Mohyuddin shared a thread on X: . "Ten important observations about myeloma and its…
May 1, 2024, 11:48 | Insight
Chadi Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
Apr 29, 2024, 23:03 | Insight
Manni Mohyuddin: Aaron Goodman and I draw attention to over treatment of multiple myeloma and its precursor states
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, recently posted on…
Apr 23, 2024, 16:51 | Insight
Neeraj Agarwal: Full protocol of our trial of creatine supplementation and resistance training in advanced prostate cancer undergoing ADT
Neeraj Agarwal shared on X: "Just in BioMed Central! Full protocol of our recently initiated,…
Apr 16, 2024, 13:01 | Career
Neli Ulrich: I am deeply honored and humbled to receive the Governor's Medal today
Neli Ulrich, Chief Scientific Officer and Executive Director of the Comprehensive Cancer Center at Huntsman…
Apr 14, 2024, 14:15 | Insight
Neeraj Agarwal: Data from SWOG 1216 trial in mHSPC
Neeraj Agarwal shared on X/Twitter: "Just in: Data from SWOG Cancer Research Network 1216 trial…
Apr 2, 2024, 05:05 | Career
Gita Suneja has been named the first senior director of Programs to Enhance Diversity - Huntsman Cancer Institute
Huntsman Cancer Institute shared on their X/Twitter page: "We are pleased to announce that Gita…
Feb 23, 2024, 14:39 | Insight
Manni Mohyuddin: Why striving for MRD negativity at all costs and having MRD as a primary endpoint may not be ideal
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Feb 11, 2024, 12:01 | Insight
Vinay Mathew Thomas: Our viewpoint article on CheckMate 901 is now out in Med by Cell Press
Petros Grivas, Associate Professor at the University of Washington, shared an X post by Vinay…
Jan 17, 2024, 17:28 | Blog
Manni Mohyuddin: This practice-changing gem of a study has changed my practice already
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, shared on X/Twitter:…
Jan 6, 2024, 11:43 | Blog
Manni Mohyuddin: Carfilzomib is NOT better than bortezomib for newly diagnosed myeloma
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on…
Dec 17, 2023, 16:45 | Opinion
Manni Mohyuddin: Sad to see surrogacy word loosely used in a plenary session
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, recently…
Dec 16, 2023, 17:08 | Blog
Manni Mohyuddin: How to treat myeloma after ASH23
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Dec 13, 2023, 08:51 | Blog
Manni Mohyuddin: So proud of Sara Zhukovsky for her excellent work on inclusion criteria in myeloma trials
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Dec 11, 2023, 11:21 | Opinion
Manni Mohyuddin: Vague enrollment criteria in smoldering myeloma trials opens door to harm/over-interventionalism
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Nov 29, 2023, 16:54 | Blog
Kimryn Rathmell: I was at a loss for words, but I decided to share a thread
Kimryn Rathmell, Chair of the Department of Medicine, Physician-in-Chief at Vanderbilt University Medical Center, shared…
Nov 6, 2023, 17:36 | Blog
Manni Mohyuddin: Every day in my clinic, there is selection bias in favor of an increase in PFS for CAR T-cell therapy
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Oct 1, 2023, 20:03 | Career
Sumanta K. Pal: I have had the distinct pleasure of working directly with Georges Gebrael.
Sumanta K. Pal, Co-director of City of Hope's Kidney Cancer Program and  head of the…
Aug 22, 2023, 18:13 | Blog,Opinion
Cannabis use associated with inferior immunotherapy outcomes OR confounding bias?
Discussions among healthcare professionals ignited on Twitter/X over the following post by Ishwaria Subbiah, the…
All: 63 Posts: 1 - 100
Special Coverage